Introduction
============

Human papillomavirus (HPV) is associated with various cancer types in both men and women. Among women, in 2012, HPV was associated with 74% of cancer cases, 70% of which were cervical cancer.[@b1-ppa-12-945] In men, HPV DNA is detected in around 50% of all penile cancers.[@b2-ppa-12-945] HPV 16, HPV 18, and HPV 6/11 are considered the most common causes of HPV-related penile tumors.[@b3-ppa-12-945]

HPV vaccination is an effective method to diminish the risk of HPV transmission in both genders.[@b5-ppa-12-945] In 2008, the US Food and Drug Administration licensed the first vaccine that could prevent 70% of cervical cancers and diseases associated with HPV 16 and HPV 18. A systematic review of cost-effectiveness analyses endorsed the need for HPV vaccine combined with screening tests to reduce costs, save time, and prolong the effects of the vaccine.[@b4-ppa-12-945] However, in developing countries, the uptake of HPV immunization among the target population remains low.[@b12-ppa-12-945]--[@b14-ppa-12-945] One study revealed that HPV vaccine uptake among Vietnamese young people (5.7%) was significantly lower than that of their US counterparts (42%).[@b15-ppa-12-945] Reasons for this phenomenon include high cost,[@b6-ppa-12-945],[@b7-ppa-12-945] lack of knowledge about the HPV vaccine,[@b8-ppa-12-945] negative attitudes toward the HPV vaccine,[@b9-ppa-12-945] and fear of side effects.[@b10-ppa-12-945],[@b11-ppa-12-945] Moreover, empirical evidence indicated that the integration of HPV vaccination into preventive strategies may face several barriers related to knowledge, attitude, practice, and willingness to pay (WTP) for this vaccine.[@b16-ppa-12-945],[@b17-ppa-12-945]

The Ministry of Health in Vietnam has exempted fees for vaccine services to children aged under 6 years, but people need the provide co-payment for other vaccines such as rubella, *Haemophilus influenzae*, hepatitis B, and HPV vaccines.[@b18-ppa-12-945] During 2006--2010, the Vietnam National Institute of Hygiene and Epidemiology collaborated with the Program for Appropriate Technology in Health to implement school-based and health center-based HPV vaccine demonstration projects to 11-year-old females.[@b19-ppa-12-945] The project ended successfully and gained a high level of public acceptability.[@b20-ppa-12-945] Since 2016, the country has no longer qualified for support from the Global Alliance for Vaccines and Immunization.[@b21-ppa-12-945] People have to pay the full price for each dose of HPV vaccine, which costs around US\$100, and this could be a financial burden.

Our study aimed to investigate knowledge--attitude--practice (KAP), WTP, and factors associated with WTP for the HPV vaccine among those using the services of an urban vaccination clinic in Hanoi, Vietnam. Our findings could be useful for the Ministry of Health in Vietnam, which is considering incorporating HPV vaccination into the national Expanded Program on Immunization.

Materials and methods
=====================

Study setting and sampling method
---------------------------------

We conducted a cross-sectional study at the Institute of Preventive Medicine and Public Health vaccination clinic, Hanoi, Vietnam, from March to April 2016. We chose this clinic based on several factors. First, it is located in the center of Hanoi; thus, the characteristics of users were likely to reflect the dynamic socioeconomic characteristics of urban people. Second, this clinic has sufficient service users to meet the study sample size. Subjects were included in the study if they met the eligibility criteria: 1) were vaccine service users, 2) were at least 18 years old, 3) agreed to enroll in the study and signed a written informed consent, and 4) were cognitively healthy.

Under the scope of this study, a convenience sampling approach was applied to recruit both male and female participants. This method allowed us to reach all available subjects in the clinic where the sampling frame was not available. After eligible subjects provided written informed consent to confirm they were invited to a private room for face-to-face interviews to ensure confidentiality. A total of 429 subjects participated in this study.

Measurements and instruments
----------------------------

Face-to-face interviews were conducted using a structured questionnaire to collect self-reported data. We were aware that our study might be affected by recall bias and social desirability bias. The former bias could occur when service users incompletely remember events in the past, while the latter bias may occur when respondents want to please the medical staff, resulting in overestimating or underestimating the outcomes of interest. We applied several solutions to address these biases. First, we recruited interviewers who were not affiliated with the vaccination clinic and received sufficient training. Second, the interviewers explained clearly the purpose of the study to the subjects before interviewing and allowed sufficient time for subjects to recall accurate memories. Third, the questionnaire was designed in an understandable way. Finally, because some couples brought their children to the clinic together, we ensured that the mother and father were not interviewed twice by checking when we invited them to the study.

### Sociodemographic characteristics

We collected data about age, gender, educational attainment, marital status, current occupation, and monthly household income.

### Knowledge, attitude, and practice about HPV vaccination

Since a validated questionnaire is not available in Vietnam, we developed a series of questions based on previous studies in settings with a similar sociocultural context to Vietnam to examine KAP about HPV vaccination, and conducted a pilot study to test the validity and reliability of the questionnaire. Knowledge about HPV vaccination was measured by asking the respondents about the target group for HPV vaccination, benefits of HPV vaccination, and the best age for vaccination. In terms of attitude, we asked people about their belief in the safety and efficacy of the vaccine and their desire for vaccine uptake by asking the following questions: "Do you believe that HPV vaccine is safe?", "Do you believe that HPV vaccine is efficient?", and "Do you want to get the HPV vaccine?" In terms of practice, we asked whether subjects have received HPV vaccinations before and, if not, the reasons why they had not received the vaccine.

### Willingness to pay for HPV vaccination

We used a contingent valuation method to examine the WTP for HPV vaccination services, with a starting price of 1.8 million VND (\~US\$81, 2016 exchange rate) ([Figure 1](#f1-ppa-12-945){ref-type="fig"}). First, subjects were asked "Are you willing to pay 1.8 million VND per dose for HPV vaccine?" The price doubled or dropped by a half depending on the respondent's answer (Yes or No). The question was repeated until the last price reached four times higher or eight times lower than the initial price. Finally, subjects were asked about the maximum price that they were willing to pay for a dose of HPV vaccine.

Statistical analysis
--------------------

Data were analyzed using STATA software (version 12.0). For missing data, the highest proportion of missing data was 6.1%, for the desire to be vaccinated. The chi-squared test was used to assess differences in sociodemographic variables (age, education, marital status, and occupation), sources of seeking HPV information, KAP about the HPV vaccine, sexually transmitted infections (STIs), and use of reproductive health services between the genders. Logistic and interval regressions were used to identify factors associated with WTP and the amount that people were willing to pay. A forward stepwise strategy with a threshold of *p*\<0.2 was applied to shorten the regression model. A *p*-value \<0.05 was considered statistically significant.

Ethics approval and informed consent
------------------------------------

The study was approved by Ethical Committee of Hanoi Medical University. Subjects were told about the purpose of this study and asked to give their written informed consent if they agreed to participate in the study. Subjects could withdraw from the study at any time without any interruption of their services at the clinic. They were assured that their information would remain confidential.

Results
=======

The majority of the sample had received at least a high-school level of education (63.2%). Half of the respondents were single, divorced, or widowed (50.6%). The mean±SD age was 26.8±6.2 years and the average monthly household income was 15.9±32.2 million VND ([Table 1](#t1-ppa-12-945){ref-type="table"}).

[Table 2](#t2-ppa-12-945){ref-type="table"} presents the different ways of seeking HPV-related information. Social networks and the internet (56.8%), and doctors, nurses, and other health professionals (41.9%) were common channels used to obtain information on the HPV vaccine. Of note, the internet, news, and television were the most popular channels used to seek HPV vaccine information, accounting for 66.8%. The rate of seeking HPV vaccine information in females was significantly higher than that in males (*p*\<0.01).

[Table 3](#t3-ppa-12-945){ref-type="table"} summarizes KAP about HPV vaccination. The percentages of subjects correctly answering questions regarding the best age for HPV vaccination, the benefits of HPV vaccination, and the target subject for HPV vaccination were 67.9%, 94.6%, and 12.3%, respectively. Regarding attitudes, the majority believed that the HPV vaccine was safe (92.8%) and effective (90.8%), and desired to get vaccinated (71.1%). However, the vaccination rate was only 31.8%, and the vaccination rate in males was nearly four times lower than in females (*p*\<0.01). The most common reasons for not having the HPV vaccine were being male (33.3%), high cost (38.2%), and the vaccine being seen as unnecessary (34.5%).

The subjects' history of STIs and use of reproductive health service are shown in [Table 4](#t4-ppa-12-945){ref-type="table"}. Most subjects had never been infected with STIs (90.1%) or genital herpes (94.4%). Nearly 30% of subjects had ever had a reproductive health examination, and 46% of these respondents were examined every 6 months.

The WTP for the HPV vaccine is presented in [Table 5](#t5-ppa-12-945){ref-type="table"}. Most respondents were willing to pay for the HPV vaccine (86.6%), with an average amount of 1.119 million VND.

[Table 6](#t6-ppa-12-945){ref-type="table"} shows that those aged 20--29 years were more likely to be willing to pay for HPV vaccine than those aged \<20 years (OR = 6.99, 95% CI 1.62 to 30.21). People who earned more than 22 million VND/month (very rich) were willing to pay for HPV vaccine at a higher price than those who earned \<7 million/month (very poor) (coefficient = 474.91, 95% CI 82.19 to 867.63). Service users who had attained education above high school were will ing to pay for the vaccine at a lower price than those had less than secondary education (coefficient = −572.98, 95% CI −936.33 to −209.64). Those who had children above 6 years old were willing to pay a higher price for the HPV vaccine (coefficient = 1,294.77, 95% CI 161.91 to 2,427.63). People who were informed about HPV by doctors, nurses, or other health professionals were willing to pay a lower price for the HPV vaccine (coefficient = −443.34, 95% CI −719.17 to −167.51).

Discussion
==========

This study provides a step toward a better understanding of barriers to HPV vaccination uptake in Hanoi, Vietnam. Our findings highlighted a low rate of service users having sufficient KAP towards HPV vaccination, but a high proportion of respondents were willing to pay for HPV vaccine, at an average cost of 1.119 million VND (US\$49.3) per dose. Moreover, some factors associated with the WTP for HPV vaccine were found, suggesting potential implications for further scaling-up of HPV vaccination in Vietnam.

In this study, we found that one-third of service users were vaccinated against HPV infection. This vaccine uptake rate (31.8%) was higher than a previous study in Vietnam (2.3%)[@b24-ppa-12-945] but lower than a study in China (47.2%), and in European countries such as Germany (53%)[@b25-ppa-12-945] and the Netherlands (49.9%).[@b26-ppa-12-945] Of note, we observed that very few people answered correctly the question about the target group for HPV vaccination. This may be explained by the fact that HPV vaccination programs have largely focused on women and young adolescent girls as there is a close link to cervical cancer.[@b22-ppa-12-945] However, this may lead to erroneous perceptions of the target group for HPV vaccination in that this vaccine is for both males and females. Moreover, men may perceive that the HPV vaccine is not necessary.[@b23-ppa-12-945] This raises the need for knowledge enhancement efforts which emphasize the benefits of HPV vaccination in both men and women.

The estimated amount that people were willing to pay for the HPV vaccine in this sample was approximately two-thirds of the actual price in the vaccination clinic (1.8 million VND per dose). This amount was lower than that in the USA,[@b27-ppa-12-945] where mothers would pay an average of US\$663 for the three-dose course. In other studies in Thailand and Mexico, people were willing to pay US\$200 for three doses and US\$45--240 for three doses,[@b28-ppa-12-945] respectively. The reason for this may be because this amount could still be a financial burden as the three-dose HPV vaccine course represented about 21% of general monthly household income and nearly 7% of Vietnamese annual income.[@b29-ppa-12-945] A previous study conducted in Binh Dinh, Vietnam, also indicated the high cost as a major barrier to HPV vaccination.[@b24-ppa-12-945] Our results highlight the need for financial support and the inclusion of the HPV vaccine in the National Immunization Program.

Our findings suggest that individuals between the ages of 20 and 29 years were most likely to pay for the vaccine. Sexual health topics are often avoided in discussions at school or in the family.[@b30-ppa-12-945] Some people even believe that sexuality and relationships are not appropriate for adolescents and young adults because education must be prioritized.[@b31-ppa-12-945] However, this may lead to a lack of essential knowledge about sexual health. In the context of Vietnam, those between 20 and 29 years old are more likely than others to be in a romantic relationship, become sexually active, and care about sexual health. Thus, the expansion of school-based sexual health education could be a vital aspect of any public health initiative to increase the knowledge regarding prevention of STIs. Although receiving HPV vaccination before becoming sexually active can reduce the risk of cervical cancer, the rate of vaccination uptake remains low owing to high prices, especially in developing countries.[@b32-ppa-12-945] Very rich subjects were more willing to pay the higher price than their very poor counterparts. While this result is in line with a previous study in Vinh Long, Vietnam,[@b18-ppa-12-945] a study in Binh Dinh, Vietnam, found no association between household economics and HPV vaccination.[@b24-ppa-12-945] Nevertheless, our study affirms the existence of financial barriers to HPV vaccination.

This study suggests that those had higher than a high-school level of education tended to pay for the vaccine at a lower price than those who had lower than the secondary-school level. This finding is in line with the previous literature.[@b33-ppa-12-945],[@b34-ppa-12-945] It is widely acknowledged that well-educated people tend to chart their own course on the issue of vaccines.[@b35-ppa-12-945],[@b36-ppa-12-945] In this respect, these people may enrich their knowledge themselves by cross-referencing reputable information on the internet, where they gather a lot of misinformation about vaccination. While a large body of literature shows that physicians play an important role in increasing HPV vaccine uptake,[@b37-ppa-12-945],[@b38-ppa-12-945] we found that subjects who had heard about the HPV vaccine from doctors, nurses, health professionals, and community health workers were less likely than others to be willing to pay for the vaccine. Several studies have pointed out that the high cost of the HPV vaccine is a major barrier to recommending the HPV vaccine.[@b39-ppa-12-945],[@b40-ppa-12-945] More affordable alternatives, such as using condoms and having a single sexual partner, may be prioritized. This could orientate people towards alternatives other than HPV vaccination. Future studies should draw attention to physicians' perceived barriers to recommending HPV vaccine. This may enrich the understanding about barriers to expanding HPV vaccine from the physician's perspective.

Several recommendations can to be drawn from the study. First, sexual health education should be extensively implemented in dynamic forms such as media, workshops, and school curriculums to promote KAP about HPV vaccination among the target populations. Second, the government should mobilize financial resources to reduce the cost of the HPV vaccine. Finally, there needs to be a strong collaboration among stakeholders to introduce the HPV vaccine into the National Immunization Program. Future research could focus on physicians' perceived barriers to recommending the HPV vaccine in the context of Vietnam, and the characteristics of those people who know little about HPV and are not willing to pay for the HPV vaccine.

This study reflects viewpoints from both males and females, which allows us to capture a more comprehensive picture of KAP and WTP for the HPV vaccine in the general population. However, we acknowledge several limitations. First, owing to the nature of the design, we cannot establish causal links between WTP for the HPV vaccine and its associated factors. Second, we recruited our sample by using the convenience sampling technique, which limits the capacity to generalize our results to other settings. Moreover, this study was carried in the vaccination clinic, where people may have better KAP and a high WTP for the HPV vaccine than those in the community. Finally, although some preventive procedures were followed, recall bias and social desirability bias may have occurred, which could affect the main findings of this study.

Conclusion
==========

Most subjects in this study had misconceptions about the target group for HPV vaccination, and the vaccination rate was low, especially in males. The majority was willing to pay for the vaccine and the average amount they were willing to pay was 1.119 million VND per dose. Age, monthly household income, having children above 6 years old, and sources of hearing about HPV were factors associated with WTP and the amount that people were willing to pay for the HPV vaccine. Enhancing sexual health education among adolescents, reducing the costs of the HPV vaccine, and introducing the HPV vaccine into the National Immunization Program could be pragmatic solutions to increase levels of HPV vaccination.
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###### 

Characteristics of respondents

  Characteristics                                                                    Female     Male     Total      *p*-value                       
  ---------------------------------------------------------------------------------- ---------- -------- ---------- ----------- ---------- -------- ---------------
  Age (years)                                                                                                                                       \<0.05
   ≤25                                                                               118        37.6     62         54.8        180        42.2     
   25--40                                                                            180        57.3     44         38.9        224        52.5     
   \>40                                                                              16         5.1      7          6.2         23         5.4      
  Ethnicity                                                                                                                                         0.09
   Kinh                                                                              308        98.4     108        95.6        416        97.7     
   Other                                                                             5          1.6      5          4.4         10         2.4      
  Educational level                                                                                                                                 \<0.01
   Secondary school or less                                                          13         4.1      2          1.8         15         3.5      
   High school                                                                       85         27.1     57         50.4        142        33.3     
   Greater than high school                                                          216        68.8     54         47.8        270        63.2     
  Religion                                                                                                                                          0.01
   None                                                                              308        98.7     106        93.8        414        97.4     
   Other                                                                             4          1.3      7          6.2         11         2.6      
  Marital status                                                                                                                                    \<0.01
   Single/divorced/widowed                                                           138        44.0     78         69.0        216        50.6     
   Living with spouse/partner                                                        176        56.1     35         31.0        211        49.4     
  Occupation                                                                                                                                        \<0.01
   Freelancer                                                                        34         11.0     12         10.6        46         10.9     
   White-collar worker                                                               149        48.1     34         30.1        183        43.3     
   Student                                                                           100        32.3     60         53.1        160        37.8     
   Other                                                                             27         8.7      7          6.2         34         8.0      
                                                                                                                                                    
                                                                                     **Mean**   **SD**   **Mean**   **SD**      **Mean**   **SD**   ***p*-value**
                                                                                                                                                    
  Age (years)                                                                        27.0       5.7      26.3       7.6         26.8       6.2      0.31
  Monthly household income (million VND[a](#tfn1-ppa-12-945){ref-type="table-fn"})   14.3       11.3     20.0       58.0        15.9       32.2     0.46

**Note:**

1 US\$ = 22,222 Vietnamese dong (VND).

###### 

Finding information on the HPV vaccine

  Characteristics                              Female   Male   Total   *p*-value                
  -------------------------------------------- -------- ------ ------- ----------- ----- ------ --------
  Heard about HPV vaccine                      276      91.4   87      77.7        363   87.7   \<0.01
  Seeking HPV vaccination information          233      84.4   46      52.9        279   76.9   \<0.01
  Source of hearing about HPV vaccine                                                           
   Friends                                     52       22.5   8       16.7        60    21.5   0.37
   Relatives                                   49       21.2   4       8.7         53    19.1   0.05
   Doctors/nurses/health professionals         99       42.9   18      37.5        117   41.9   0.49
   Books/newspapers                            65       28.1   14      29.8        79    28.4   0.82
   Social network/internet                     134      58.0   24      51.1        158   56.8   0.38
  Source for finding HPV vaccine information                                                    
   Community health worker                     29       11.5   4       5.8         33    10.3   0.17
   Staff at vaccination clinic                 74       29.0   8       11.6        82    25.3   \<0.01
   Internet/news/television                    167      65.2   50      72.5        217   66.8   0.26
   National guideline                          13       5.1    3       4.4         16    5.0    0.79
   Relatives/friends/colleagues                95       37.0   23      33.3        118   36.2   0.58
   Other                                       11       4.2    9       11.5        20    5.9    0.02

**Abbreviation:** HPV, human papillomavirus.

###### 

Knowledge--attitude--practice about the HPV vaccine

  Characteristics                                  Female   Male   Total   *p*-value                
  ------------------------------------------------ -------- ------ ------- ----------- ----- ------ --------
  Knowledge about HPV vaccine                                                                       
   Targeted subject for HPV vaccination                                                             
    Male                                           32       11.9   15      19.5        47    13.6   0.09
    Female                                         264      98.5   77      100.0       341   98.8   0.28
    Both male and female                           28       10.3   15      19.2        43    12.3   \<0.05
   Benefits of HPV vaccine                                                                          
    Prevent cervical cancer                        263      97.2   67      86          330   94.6   \<0.01
    Treat cervical cancer                          2        0.8    4       5.1         6     1.7    
    Unknown                                        7        2.6    9       11.5        16    4.6    
   Places providing HPV vaccine service                                                             
    Hospital                                       145      56.9   48      68.6        193   59.4   0.08
    Immunization facility                          221      87.0   56      80.0        277   85.5   0.14
   Age for highest effectiveness of vaccine                                                         
    9--25 years, never had sex                     197      73.0   38      50.0        235   67.9   \<0.01
    9--25 years                                    24       8.9    4       5.3         28    8.1    
    Before having sex                              6        2.2    2       2.6         8     2.3    
    Other                                          30       11.1   20      26.3        50    14.5   
    Unknown                                        13       4.8    12      15.8        25    7.2    
  Attitude about HPV vaccine                                                                        
   Believes that HPV vaccine is safe               251      92.6   70      93.3        321   92.8   0.83
   Believes that HPV vaccine is effective                                                           
    Yes                                            244      90.0   70      93.3        314   90.8   0.63
    No                                             8        3.0    1       1.3         9     2.6    
    Unknown                                        19       7.0    4       5.3         23    6.7    
   Desire to have HPV vaccine injection                                                             
    Yes, certainly                                 212      78.5   54      72.0        266   77.1   0.36
    Possibly                                       53       19.6   18      24.0        71    20.6   
    No                                             5        1.9    3       4.0         8     2.3    
   Most influential person to inject HPV vaccine                                                    
    Doctor/nurse/health professional               96       32.2   38      34.9        134   32.9   0.62
    Teacher                                        15       5.0    4       3.7         19    4.7    0.58
    Friend                                         23       7.7    17      15.6        40    9.8    0.02
    Family                                         48       16.1   18      16.5        66    16.2   0.92
    Oneself                                        127      42.6   37      34.6        164   40.5   0.15
    Other                                          4        1.3    3       2.7         7     1.7    0.33
  Practice of HPV vaccine                                                                           
   Has ever had HPV vaccine injection              102      37.6   8       10.7        110   31.8   \<0.01
   Reason not to inject                                                                             
    High cost                                      51       56.0   7       11.5        58    38.2   \<0.01
    Unnecessary                                    39       44.3   12      20.0        51    34.5   \<0.01
    Male                                           3        3.7    44      73.3        47    33.3   \<0.01
    Unsuitable age                                 49       30.6   2       2.9         51    22.4   \<0.01
    Lack of knowledge                              14       8.8    4       5.9         18    7.9    0.46
    Not sufficient condition                       14       8.8    1       1.5         15    6.6    \<0.05
    Lack of trust                                  2        1.3    0       0.0         2     0.9    0.35
    Using other vaccine                            1        0.6    0       0.0         1     0.4    0.51
    Afraid of pain                                 1        0.6    0       0.0         1     0.4    0.51

**Abbreviation:** HPV, human papillomavirus.

###### 

History of STIs and reproductive health service use

  Characteristics                                Female   Male   Total   *p*-value                
  ---------------------------------------------- -------- ------ ------- ----------- ----- ------ --------
  Ever had STI                                                                                    0.08
   Yes                                           27       8.9    3       2.7         30    7.3    
   No                                            268      88.7   104     93.7        372   90.1   
   Unknown                                       7        2.3    4       3.6         11    2.7    
  Ever had genital herpes                                                                         0.39
   Yes                                           5        1.7    3       2.7         8     1.9    
   No                                            283      94.0   106     95.5        389   94.4   
   Unknown                                       13       4.3    2       1.8         15    3.6    
  Family member ever had STI                                                                      0.24
   Yes                                           7        2.3    0       0.0         7     1.7    
   No                                            272      90.1   104     93.7        376   91.0   
   Unknown                                       23       7.6    7       6.3         30    7.3    
  Knows people who have had cervical cancer                                                       0.23
   Yes                                           12       4.0    1       0.9         13    3.1    
   No                                            277      91.1   107     95.5        384   92.3   
   Unknown                                       15       4.9    4       3.6         19    4.6    
  Ever examined reproductive health              105      34.8   6       5.4         111   26.9   \<0.01
  Frequency of reproductive health examination                                                    0.09
   Every 3 months                                14       13.3   3       50.0        17    15.3   
   Every 6 months                                50       47.6   1       16.7        51    46.0   
   Every 1 year                                  33       31.4   2       33.3        35    31.5   
   Over 1 year                                   8        7.6    0       0.0         8     7.2    

**Abbreviation:** STI, sexually transmitted infection.

###### 

WTP for the HPV vaccine

  Characteristics               WTP   Amount willing to pay (VND)                    
  ----------------------------- ----- ----------------------------- ------ --------- --------------------
  Total                         349   86.6                                 1,119.9   1,010.3 to 1,229.4
  Gender                                                            0.18             
   Female                       256   88.0                                 1,084.0   962.1 to 1,206.0
   Male                         92    82.9                                 1,231.7   990.9 to 1,472.6
  Age (years)                                                       0.97             
   \<20                         8     88.9                                 1,523.1   619.1 to 2,427.1
   20--29                       248   86.7                                 1,119.9   993.4 to 1,246.3
   ≥30                          93    86.1                                 1,084.6   864.0 to 1,305.3
  Educational level                                                 0.86             
   Secondary school or less     11    91.7                                 782.7     243.7 to 1,321.6
   High school                  119   86.9                                 1,279.0   1,085.2 to 1,472.8
   More than high school        218   86.2                                 1,056.7   920.3 to 1,193.1
  Marital status                                                    0.65             
   Single/divorced/widowed      179   87.3                                 1,141.9   993.4 to 1,290.5
   Living with spouse/partner   169   85.8                                 1,101.8   939.4 to 1,264.3
  Employment                                                        0.13             
   Freelancer                   33    75.0                                 864.3     568.6 to 1,160.0
   White-collar worker          152   88.4                                 1,107.8   936.9 to 1,278.7
   Student                      134   87.6                                 1,202.9   1,022.4 to 1,383.4
   Other                        27    87.1                                 1,230.6   838.1 to 1,623.0

**Abbreviations:** WTP, willingness to pay; HPV, human papillomavirus.

###### 

Factors associated with WTP and amount willing to pay for the HPV vaccine

  Characteristics                                                              WTP for HPV vaccine                                   Amount willing to pay (VND)                                                            
  ---------------------------------------------------------------------------- ----------------------------------------------------- ----------------------------- -------------------------------------------------------- --------------------
  Vaccine service user (vs children)                                                                                                                                                                                        
   Adult male                                                                  0.12[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}   0.03 to 0.52                  −271.32                                                  −664.03 to 121.40
  Age (vs \<20 years)                                                                                                                                                                                                       
   20--29 years                                                                6.99[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}   1.62 to 30.21                                                                          
   ≥30 years                                                                                                                                                       −323.61[\*](#tfn8-ppa-12-945){ref-type="table-fn"}       −683.20 to 35.98
  Marital status (living with spouse/partner vs single/divorced/widowed)                                                                                           532.75[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}    167.71 to 897.78
  Education (vs secondary school or less)                                                                                                                                                                                   
   High school                                                                 3.30                                                  0.72 to 15.06                                                                          
   More than high school                                                                                                                                           −572.98[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}   −936.33 to −209.64
  Employment (vs freelancer)                                                                                                                                                                                                
   White-collar worker                                                         6.00[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}     1.35 to 26.59                                                                          
  Household income (million VND/month) (vs \<7 million VND/month, very poor)                                                                                                                                                
   7--10 (poor)                                                                0.28[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}     0.09 to 0.95                                                                           
   10--20 (rich)                                                                                                                                                   303.64                                                   −102.51 to 709.79
   20--600 (very rich)                                                         11.61[\*](#tfn8-ppa-12-945){ref-type="table-fn"}      0.66 to 203.74                474.91[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}      82.19 to 867.63
  Has children (vs no children)                                                                                                                                                                                             
   Has children \>6 years old                                                                                                                                      1,294.77[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}    161.91 to 2,427.63
  Source of hearing about HPV (vs no)                                                                                                                                                                                       
   Doctors/nurses/health professionals                                         0.18[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}   0.05 to 0.59                  −443.34[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}   −719.17 to −167.51
   Social network/internet                                                                                                                                         204.28                                                   −79.47 to 488.03
  Source for finding HPV information (vs no)                                                                                                                                                                                
   Community health worker                                                                                                                                         −550.15[\*\*\*](#tfn6-ppa-12-945){ref-type="table-fn"}   −967.00 to −133.31
   Website/newspaper/television                                                                                                                                    −324.51[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}     −616.88 to −32.14
  Believes that HPV vaccine is safe (yes vs no)                                                                                                                    440.58[\*](#tfn8-ppa-12-945){ref-type="table-fn"}        −20.91 to 902.07
  Believes that HPV vaccine is effective (yes vs no)                           0.08[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}     0.01 to 0.62                                                                           
  Has ever examined reproductive health (yes vs no)                            0.23[\*\*](#tfn7-ppa-12-945){ref-type="table-fn"}     0.06 to 0.91                                                                           
  Has family member who ever had STI (yes vs no)                               13.26[\*](#tfn8-ppa-12-945){ref-type="table-fn"}      0.73 to 241.17                                                                         

**Note:**

*p*\<0.01,

*p*\<0.05,

*p*\<0.1.

**Abbreviations:** HPV, human papillomavirus; WTP, willingness to pay; VND, Vietnamese dong; STI, sexually transmitted infection.
